| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +50.00% | +5.97% | +2.31% | +3.66% | +3.66% | — |
| 14d | 2 | +50.00% | +18.77% | +3.70% | +15.06% | +15.06% | — |
| 30d | 2 | +100.00% | +3.17% | +3.59% | -0.43% | -0.43% | — |
| 60d | 2 | +100.00% | +42.45% | -1.56% | +44.01% | +44.01% | — |
| 90d | 2 | +50.00% | -32.26% | -1.59% | -30.66% | -30.66% | — |
| 180d | 2 | +50.00% | -40.52% | +8.69% | -49.21% | -49.21% | — |
| 1y | 2 | +100.00% | -7.41% | +21.78% | -29.18% | -29.18% | — |
| 2y | 2(1 pending) | +100.00% | -59.67% | +38.65% | -98.32% | -98.32% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| IBIO IBIO, INC. | PURCHASEGRANT Stock grant | 13,500 | — | — | 13,500 | Nov 20, 2025 | Nov 24, 2025 ↗ | View → |
| IBIO IBIO, INC. | PURCHASE | 18,382 | $2.72 | $50.0K | 18,382 | Jan 10, 2025 | Jan 13, 2025 ↗ | View → |
| IBIO IBIO, INC. | PURCHASEGRANT Stock grant | 12,600 | — | — | 12,600 | Nov 21, 2024 | Nov 25, 2024 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 3,939 | $1.08 | $4.3K | 182,442 | Feb 16, 2024 | Feb 16, 2024 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 10,625 | — | — | 186,381 | Feb 15, 2024 | Feb 16, 2024 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | SALE Chief Financial Officer | 10,625 | — | — | 31,875 | Feb 15, 2024 | Feb 16, 2024 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 35,625 | — | — | 35,625 | Feb 14, 2024 | Feb 16, 2024 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 213,750 | — | — | 213,750 | Feb 14, 2024 | Feb 16, 2024 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 287,905 | — | — | 287,905 | Feb 14, 2024 | Feb 16, 2024 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 4,066 | $1.35 | $5.5K | 175,756 | Oct 30, 2023 | Oct 31, 2023 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | SALE Chief Financial Officer | 13,209 | — | — | 13,209 | Oct 27, 2023 | Oct 31, 2023 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 13,209 | — | — | 179,822 | Oct 27, 2023 | Oct 31, 2023 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 42,500 | — | — | 166,613 | Apr 27, 2023 | May 1, 2023 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 26,418 | — | — | 26,418 | Apr 27, 2023 | Oct 31, 2023 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 85,000 | — | — | 85,000 | Feb 3, 2023 | Feb 7, 2023 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 42,500 | — | — | 42,500 | Feb 3, 2023 | Feb 7, 2023 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 42,500 | — | — | 112,992 | Oct 27, 2022 | Oct 31, 2022 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 63,492 | $3.15 | $200.0K | 65,492 | Jul 5, 2022 | Jul 6, 2022 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 5,000 | — | — | 70,492 | Jun 15, 2022 | Oct 31, 2022 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | SALE Chief Financial Officer | 5,000 | — | — | 0 | Jun 15, 2022 | Oct 31, 2022 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 190,000 | — | — | 190,000 | Feb 4, 2022 | Feb 8, 2022 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 5,000 | — | — | 5,000 | Jun 1, 2021 | Jun 1, 2021 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 270,000 | — | — | 270,000 | Jun 1, 2021 | Jun 1, 2021 ↗ | View → |